By Josh White
Date: Monday 09 Jun 2025
(Sharecast News) - Ondine Biomedical announced new data from University College London on Monday, showing that its Steriwave photodisinfection technology is effective against Mucor, a highly lethal fungal pathogen that poses significant risks to immunocompromised patients.
By Josh White
Date: Thursday 05 Jun 2025
(Sharecast News) - Ondine Biomedical announced on Thursday that the University of Ottawa Heart Institute (OHI) had adopted its Steriwave nasal photodisinfection therapy as a standard of care for all cardiac surgeries, marking a major institutional endorsement of the infection prevention technology.
By Josh White
Date: Friday 09 May 2025
(Sharecast News) - Ondine Biomedical announced the appointment of Alan Thomas as its interim chief financial officer on Friday, with immediate effect, following the departure of Michael Behlke, who was stepping down from his role as CFO and chief operating officer for personal reasons.
Currency | UK Pounds |
Share Price | 13.75p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 14.50 |
52 Week Low | 5.63 |
Volume | 105,158 |
Shares Issued | 443.43m |
Market Cap | £60.97m |
Beta | 0.06 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:13 | 72,159 @ 13.85p |
16:20 | 600 @ 14.00p |
16:20 | 1,912 @ 13.50p |
16:20 | 70 @ 13.50p |
10:04 | 14,620 @ 13.72p |
Chair | Jean Charest |
CEO | Carolyn Cross |
You are here: research